Exploring the Role of Chat GPT in patient care (diagnosis and Treatment) and medical research: A Systematic Review ================================================================================================================== * Ravindra Kumar Garg * Vijeth L Urs * Akshya Anand Agrawal * Sarvesh Kumar Chaudhary * Vimal Paliwal * Sujita Kumar Kar ## ABSTRACT **Importance** In 2021, the American Academy of Pediatrics published a policy statement seeking to create a paradigm shift away from a focus on childhood toxic stress and toward the emphasis on early relational health (ERH) as a buffer for childhood adversity and promoter of life-course resilience. A comprehensive appraisal of the efficacy of contemporary parent/caregiver-child interventions in – primarily – improving ERH, and – secondarily – enhancing child well-being and neurodevelopment is needed to guide widespread implementation and policy. **Objective** Determine the effectiveness of contemporary early dyadic parent/caregiver-infant interventions on ERH, child socio-emotional functioning and development, and parent/caregiver mental health. **Data Sources** PubMed, Medline, Cinhal, ERIC, and PsycInfo were searched on April 28, 2022. Additional sources: clinical trial registries (clinicaltrials.gov, ISRCTN Registry, EU Clinical Trials Register, Australian New Zealand Clinical Trials Registry), contacting authors of unpublished/ongoing studies, backward/forward reference-searching. **Study Selection** Studies targeting parent/caregiver-infant dyads and evaluating effectiveness of a dyadic intervention were eligible. Study selection was performed in duplicate, using Covidence. **Data Extraction and Synthesis** Cochrane’s methodological guidance presented per PRISMA guidelines. Data extraction and risk of bias assessment were completed in duplicate with consensuses by first author. Data were pooled using inverse-variance random effects models. **Main Outcomes and Measures** The primary outcome domain was ERH. Secondary outcome domains were child socio-emotional functioning and development, and parent/caregiver mental health, and were only considered in studies where at least one ERH outcome was also measured. The association between dose of intervention and effect estimates was explored. **Results** 93 studies (14,993 parent/caregiver-infant dyads) met inclusion criteria. Based on very low to moderate quality of evidence, we found significant non-dose-dependent intervention effects on several measures of ERH, including bonding, parent/caregiver sensitivity, attachment, and dyadic interactions, and a significant effect on parent/caregiver anxiety, but no significant effects on other child outcomes. **Conclusion** Current evidence does not support the notion that promoting ERH through early dyadic interventions ensures optimal child development, despite effectively promoting ERH outcomes. Given the lack of an association with dose of intervention, the field is ripe for novel, innovative, cost-effective, potent ERH intervention strategies that effectively and equitably improve meaningful long-term child outcomes. ### Competing Interest Statement Dr. Dumitriu reported personal fees for lectures and round-table discussions from Medela outside the submitted work. The Nurture Science Program (NSP) at Columbia University Irving Medical Center has conducted one RCT included in this systematic review (Hane 2015) prior to Dr. Dumitriu being appointed director of the NSP. No other disclosures were reported. ### Clinical Protocols [https://www.crd.york.ac.uk/prospero/display\_record.php?RecordID=329894](https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=329894) ### Funding Statement This work was supported by grant R01MH126531 from National Institute of Mental Health (Dumitriu), grant P-6006251-2021 from W.K. Kellogg Foundation (Dumitriu), gift funds from Einhorn Collaborative (Dumitriu), and grant 201910MFE-430349-268206 from Canadian Institutes of Health Research (Lavallee). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This systematic review analyzed human subject data from already published studies. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes ## Footnotes * - Title: Updated to clarify scope of review. - Author list: Author added for significant biostatistic contribution. - Analysis plan: Revised and Updated. ## Data Availability All data produced in the present study are available upon reasonable request to the authors * Received October 29, 2022. * Revision received May 22, 2023. * Accepted May 23, 2023. * © 2023, Posted by Cold Spring Harbor Laboratory The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.